Close Menu

NEW YORK – As the COVID-19 pandemic continues with no sign of letting up, researchers across the world are looking into ways to help physicians treat and manage patients with the virus more effectively.

A new study led by researchers at the Royal College of Surgeons in Ireland's University of Medicine and Health Sciences in Dublin makes the case that measuring and comparing certain interleukin biomarkers could provide information about how severe a patient's response to SARS-CoV-2 will be in advance. 

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.